Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng.
Saved in:
| Title: | Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng. |
|---|---|
| Authors: | Aizenbud L; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA., Schoenfeld DA; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA., Caulfield JI; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA., Mann JE; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA., Austin MR; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA., Perdigoto AL; Department of Medicine (Endocrinology and Metabolism), Yale University School of Medicine, New Haven, Connecticut, USA., Herold KC; Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA., Kluger HM; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA Harriet.Kluger@Yale.edu. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jun; Vol. 11 (6). |
| Publication Type: | Letter; Research Support, N.I.H., Extramural; Comment |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37349129 AccessLevel: 2 PubType: Report PubTypeId: report PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Aizenbud+L%22">Aizenbud L</searchLink>; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Schoenfeld+DA%22">Schoenfeld DA</searchLink>; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Caulfield+JI%22">Caulfield JI</searchLink>; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Mann+JE%22">Mann JE</searchLink>; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Austin+MR%22">Austin MR</searchLink>; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Perdigoto+AL%22">Perdigoto AL</searchLink>; Department of Medicine (Endocrinology and Metabolism), Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Herold+KC%22">Herold KC</searchLink>; Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Kluger+HM%22">Kluger HM</searchLink>; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA Harriet.Kluger@Yale.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2023 Jun; Vol. 11 (6). – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Research Support, N.I.H., Extramural; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37349129 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/jitc-2023-007397 Languages: – Code: eng Text: English Titles: – TitleFull: Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Aizenbud L – PersonEntity: Name: NameFull: Schoenfeld DA – PersonEntity: Name: NameFull: Caulfield JI – PersonEntity: Name: NameFull: Mann JE – PersonEntity: Name: NameFull: Austin MR – PersonEntity: Name: NameFull: Perdigoto AL – PersonEntity: Name: NameFull: Herold KC – PersonEntity: Name: NameFull: Kluger HM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2023 Jun Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2051-1426 Numbering: – Type: volume Value: 11 – Type: issue Value: 6 Titles: – TitleFull: Journal for immunotherapy of cancer Type: main |
| ResultId | 1 |
